Roche China CEO preps for a move to Merck KGaA while US Merck adds to C-suite; Succession plan finalized for EVPs retiring from Sanofi
→ Beginning Oct. 1, Roche China CEO Hong Chow will be head of China & international for Merck KGaA’s healthcare business, a position that also encompasses Japan, Europe, Latin America, Asia-Pacific, the Middle East, Africa and Russia. The multi-pronged position also has Chow leading the cardiovascular metabolism & endocrinology franchise and the Global Business Innovation (GBI) unit. A Bayer alum, Chow has helmed Roche China since 2015.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.